Also, researchers observed that GNPNAT1 was significantly up-regulated in prostate cancer (Kaushik et al., 2016), and GNPNAT1 low expression led to reduced proliferation of tumor cells in lung cancer receiving chemotherapy (Zhao et al., 2017). This evidence concerns the gene GNPNAT1 and lung carcinoma.